Deciphering the Etiology of Weight Loss Following Pancreatectomy
Recurrence rates after resection for pancreatic cancer are high, with [...]
Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC)
Background Limited information is available on the relevant prognostic variables [...]
Deciphering the Etiology of Weight Loss Following Pancreatectomy
Recurrence rates after resection for pancreatic cancer are high, with [...]
Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC)
Background Limited information is available on the relevant prognostic variables [...]
Clinical impact of atrophic changes in remnant pancreas on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy
Abstract Aim: The aim of this study was to evaluate [...]
Analysis of Intraoperative Frozen Pancreatic Resection Margin and Prediction of Postoperative Pancreatic Fistula Risk During Pancreatoduodenectomy
BACKGROUND: Pancreatic duct diameter and pancreatic texture are important predictive [...]
Minimally-invasive versus open pancreatoduodenectomies with vascular resection: A 1:1 propensity-matched comparison study
Background: Minimally invasive pancreatic pancreatoduodenectomy (MIPD) is increasingly adopted worldwide and [...]
Comment on: Learning Curve From 450 Cases of Robot-Assisted Pancreaticoduodenectomy in a High-Volume Pancreatic Center
We read with interest the findings of Peng et al. [...]
Preemptive Administration of Albumin during Pancreatectomy Does Not Reduce Postoperative Complications: A Prospective Randomized Controlled Trial
Despite the empirical use of human albumin during pancreatectomy to [...]
Synchronous double primary malignancies of the pancreatic body and extrahepatic bile duct treated with pancreatoduodenectomy and splenic artery resection following neoadjuvant chemotherapy with gemcitabine plus nab-paclitaxel: a case report
Background Primary pancreatic cancer with synchronous primary tumors in other [...]
It is the lymph node ratio that determines survival and recurrence patterns in resected distal cholangiocarcinoma. A multicenter international study
Background Distal cholangiocarcinoma (dCC) is still associated with a poor overall survival [...]
Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis
Background Neoadjuvant treatment is important for improving the rate of [...]
A locally advanced pancreatic body cancer presenting common bile duct invasion resected via distal pancreatectomy after gemcitabine plus nab-paclitaxel chemotherapy: A case report
Introduction The locally advanced pancreatic cancer has been steadily recognized as a [...]
Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity
Background Patients with borderline resectable pancreatic cancer (BRPC) or locally [...]
It is the lymph node ratio that determines survival and recurrence patterns in resected distal cholangiocarcinoma. A multicenter international study
Background Distal cholangiocarcinoma (dCC) is still associated with a poor overall survival [...]
Concomitant splenic artery ligation has no preventive effect on left-sided portal hypertension following pancreaticoduodenectomy with the resection of the portal and superior mesenteric vein confluence for pancreatic ductal adenocarcinoma
Background: Left-sided portal hypertension (LSPH) caused by splenic vein (SV) [...]
Extensive (subtotal) distal pancreatectomy for pancreatic ductal adenocarcinoma: a propensity score matched cohort study of short- and long-term outcomes compared with those of conventional distal pancreatectomy
Purpose Extensive distal pancreatectomy (ExDP) can transect the pancreatic parenchyma [...]
Pancreatic ductal adenocarcinoma: Prognostic indicators of advanced disease
Background/Objectives Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy associated [...]
Robotic versus open pancreaticoduodenectomy with vascular resection for pancreatic ductal adenocarcinoma: surgical and oncological outcomes from pilot experience
Purpose Venous resection and reconstruction (VR) is a feasible surgical [...]
Long-term oncological prognosis after curative-intent liver resection for hepatocellular carcinoma in the young versus the elderly: multicentre propensity score-matching study
Background Hepatocellular carcinoma (HCC) is the most common malignancy in [...]
The expression and survival significance of sodium glucose transporters in pancreatic cancer
Abstract Background Sodium glucose transporters (SGLTs) play vital roles in [...]
Weight Tracking as a Novel Prognostic Marker After Pancreatectomy
Abstract Background Objective measures of post-pancreatectomy weight change for pancreatic [...]
Comparison of oncologic outcomes between open and laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma using data from the KOTUS-BP national database: overcoming selection bias and the necessity of definite indications
Abstract Background Despite the lack of high-level evidence, laparoscopic distal [...]
What is the impact of zinc deficiency for pancreatectomies in patients with pancreatic ductal adenocarcinoma?
Abstract Background and purpose: Zinc is an essential element for [...]